| Application no. and date | 15722211.8 (espacenet) (Federated) (European Patent Register), 20150513 | | Patent/reg. no. and date | DK/EP 3143042, 20200610 | | Publication date | 20170322 | | Priority no. and date | US 201461994552 P, 20140516, US 201461014015 P, 20140618, US 201462040167 P, 20140821, US 201462047560 P, 20140908, US 201562133600 P, 20150316 | | EP pub. no. and date |
EP 3143042 20170322 | | Effective date | | | Applicant/owner | Ablynx N.V., Technologiepark 21
9052 Ghent-Zwijnaarde, BE | | Applicant ref. no. | 1554750 | | Inventor | BOUTTON, Carlo, Rijksweg 115
8710 Wielsbeke, BE,
BUYSE, Marie-Ange, Burgemeester Edmond Ronsestraat 23
9820 Merelbeke, BE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07K 16/00 (2006.01) , C07K 16/18 (2006.01) , C07K 16/28 (2006.01) | | Title | FORBEDREDE VARIABLE IMMUNOGLOBULINDOMÆNER | | Int. application no. | EP2015060643 | | Int. publication no. | WO2015173325 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
